Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Our team has published about how the heparin proteoglycan mimic APAC impacts the interplay between complement system and coagulation.
The regulatory functions and cellular clearance of debris are supported – an anti-inflammatory effect aligning with the antithrombotic mechanisms of APAC (by Aplagon).”
Title: Interactions of Antiplatelet, Anticoagulant (APAC) with C1q and FH modulate complement activation on injured cells
Authors: Juha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, Riitta Lassila, Seppo Meri
Read the Full Article on Blood Vessels, Thrombosis and Hemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 19, 2026, 16:59Rupam Manna: Not All Portal Vein Involvement in HCC Is the Same
-
Jul 19, 2026, 16:58Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
-
Jul 19, 2026, 16:58Aviva Schwartz: Air Pollution and Women’s Hematological Health in the Spotlight at ISTH 2026
-
Jul 19, 2026, 16:56Lola Sepot-Boucherit: Reimagining the Future of Rare Bleeding Disorders at ISTH 2026
-
Jul 19, 2026, 16:54Belén de la Morena Barrio: Presenting Our Research on Long-Read Sequencing for Genetic Diagnosis at ISTH 2026
-
Jul 19, 2026, 16:52Shamee Shastry: Sometimes the Answer is Not in the Test Tube Alone, but at the Patient’s Bedside
-
Jul 19, 2026, 16:52Manuela Albisetti: Congratulations to Alessandra Bosch on an Outstanding ISTH 2026 Talk
-
Jul 19, 2026, 16:44Fernanda Orsi: A Memorable Week of Science and Collaboration at ISTH 2026
-
Jul 19, 2026, 16:37William Aird: A Visual Guide to Understanding von Willebrand Disease